Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

Fast gapped-read alignment with Bowtie 2

Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

[20] Processing of X-ray diffraction data collected in oscillation mode

Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475

Coot : model-building tools for molecular graphics

Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571

Analyzing real-time PCR data by the comparative CT method

Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190

Phaser crystallographic software

McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612

Model-based Analysis of ChIP-Seq (MACS)

Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386

Refinement of Macromolecular Structures by the Maximum-Likelihood Method

Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

Shevchenko, A., Wilm, M. S., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,996

Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization

Teuscher, K. B., Meyers, K. M., Wei, Q., Mills, J. J., Tian, J., Alvarado, J., Sai, J., Meveren, M. V., South, T. M., Rietz, T. A., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00195 · Cited by 34

Facile target validation in an animal model with intracellularly expressed monobodies

Gupta, A., Xu, J., Lee, S. H. F., Tsai, S. T., Zhou, B. O., Kurosawa, K., Werner, M. S., Koide, A., Ruthenburg, A. J., Dou, Y., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0099-z · Cited by 33

Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5

Chen, Y., Su, H., Zhao, J., Na, Z., Jiang, K., Bacchiocchi, A., Loh, K. H., Halaban, R., Wang, Z., Cao, X., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113145 · Cited by 32

Understanding the Complexity of Epigenetic Target Space

Pande, V. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01507 · Cited by 35

Aberrant Activity of Histone–Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis

Poręba, E., Leśniewicz, K., & Durzyńska, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249340 · Cited by 31

Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity

Chen, W., Chen, X., Li, D., Wang, X., Long, G., Jiang, Z., You, Q., & Guo, X. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113677 · Cited by 31

Dynamic alterations of H3K4me3 and H3K27me3 at ADAM17 and Jagged‐1 gene promoters cause an inflammatory switch of endothelial cells

Katakia, Y. T., Thakkar, N. P., Thakar, S., Sakhuja, A., Goyal, R., Sharma, H., Dave, R., Mandloi, A., Basu, S., Nigam, I., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30579 · Cited by 32

Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells

Noack, K., Mahendrarajah, N., Hennig, D., Schmidt, L., Grebien, F., Hildebrand, D., Christmann, M., Kaina, B., Sellmer, A., Mahboobi, S., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1878-5 · Cited by 30

A Binary Arginine Methylation Switch on Histone H3 Arginine 2 Regulates Its Interaction with WDR5

Lorton, B. M., Harijan, R. K., Burgos, E. S., Bonanno, J. B., Almo, S. C., & Shechter, D. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00035 · Cited by 30

Methyltransferase inhibitors for modulation of the epigenome and beyond

Schapira, M., & Arrowsmith, C. H. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.05.030 · Cited by 31

WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells

Punzi, S., Balestrieri, C., D’Alesio, C., Bossi, D., Dellino, G. I., Gatti, E., Pruneri, G., Criscitiello, C., Lovati, G., Meliksetyan, M., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1216-y · Cited by 29

Insights on the regulation of the MLL/SET1 family histone methyltransferases

Liang, S., Ayoub, A. M., Cho, U., & Dou, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194561 · Cited by 33

Combined morphological and proteome profiling reveals target-independent impairment of cholesterol homeostasis

Schneidewind, T., Brause, A., Schölermann, B., Sievers, S., Pahl, A., Sankar, M. G., Winzker, M., Janning, P., Kumar, K., Ziegler, S., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.06.003 · Cited by 29

Evolution of AF6-RAS association and its implications in mixed-lineage leukemia

Smith, M. J., Ottoni, E., Ishiyama, N., Goudreault, M., Haman, A., Meyer, C., Tucholska, M., Gasmi-Seabrook, G. M. C., Menezes, S., Laister, R. C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01326-5 · Cited by 28

Targeting histone modifiers in bladder cancer therapy — preclinical and clinical evidence

Zhang, S., Lin, T., Xiong, X., Chen, C., Tan, P., & Wei, Q. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00857-z · Cited by 30

Dormant state of quiescent neural stem cells links Shank3 mutation to autism development

Kim, H., Cho, B., Park, H., Kim, J., Kim, S., Shin, J., Lengner, C. J., Won, K., & Kim, J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01563-1 · Cited by 33

Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation

Cai, W. L., Chen, J. F.-Y., Chen, H., Wingrove, E., Kurley, S. J., Chan, L.-H., Zhang, M., Estape, A. A., Zhao, M., Balabaki, A., et al. (2022) · eLife · doi:10.7554/elife.78163 · Cited by 27

Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development

Arede, L., & Pina, C. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.10.003 · Cited by 27

Chemical biology and pharmacology of histone lysine methylation inhibitors

Barghout, S. H., Machado, R. A. C., & Baršytė-Lovejoy, D. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194840 · Cited by 29

Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genesPreprint

Belhocine, M., Simonin, M., Flores, J. D. A., Cieślak, A., Manosalva, I., Pradel, L. C., Smith, C. L., Mathieu, È.-L., Charbonnier, G., Martens, J. H. A., et al. (2021) · Genome Research · doi:10.1101/gr.266924.120 · Cited by 27

Gain‐of‐Function Effects of N‐Terminal CEBPA Mutations in Acute Myeloid Leukemia

Schmidt, L., Heyes, E., & Grebien, F. (2020) · BioEssays · doi:10.1002/bies.201900178 · Cited by 26

RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer

Rossi, T., Pistoni, M., Sancisi, V., Gobbi, G., Torricelli, F., Donati, B., Ribisi, S., Gugnoni, M., & Ciarrocchi, A. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0564 · Cited by 26

Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription

Fan, Z., He, L., Li, M., Cao, R., Deng, M., Ping, F., Liang, X., He, Y., Wu, T., Tao, X., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.09.004 · Cited by 28

The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer

Pai, C.-P., Wang, H., Seachrist, D. D., Agarwal, N., Adams, J. A., Liu, Z., Keri, R. A., Cao, K., Schiemann, W. P., & Kao, H. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01294-6 · Cited by 25

Persistent epigenetic memory impedes rescue of the telomeric phenotype in human ICF iPSCs following DNMT3B correction

Toubiana, S., Gagliardi, M., Papa, M., Manco, R., Tzukerman, M., Matarazzo, M. R., & Selig, S. (2019) · eLife · doi:10.7554/elife.47859 · Cited by 25

Targeting Epigenetic protein–protein Interactions With small-molecule Inhibitors

Linhares, B. M., Grembecka, J. E., & Cierpicki, T. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0082 · Cited by 26

Oxidative stress abrogates the degradation of KMT2D to promote degeneration in nucleus pulposus

Xu, W., Zhang, X., Liu, G., Zhu, M., Wu, Y., Jie, Z., Xie, Z., Wang, S., Ma, Q., Fan, S., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165888 · Cited by 26

WDR5 is required forDUX4expression and its pathological effects in FSHD muscular dystrophy

Mocciaro, E., Giambruno, R., Micheloni, S., Cernilogar, F. M., Andolfo, A., Consonni, C., Pannese, M., Ferri, G., Runfola, V., Schotta, G., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad230 · Cited by 22

Chemical inhibitors targeting histone methylation readers

Huang, X., Chen, Y., Xiao, Q., Shang, X., & Liu, Y. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108614 · Cited by 24

SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis

Yu, P.-C., Hou, D., Chang, B., Liu, N., Xu, C., Chen, X., Hu, C.-L., Liu, T., Wang, X., Zhang, Q., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.04.023 · Cited by 24

A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins

(2024) · doi:10.1021/acs.jmedchem.4c02010 · Cited by 24

The transcription factor code: a beacon for histone methyltransferase docking

Garcia, G. T., & Graf, T. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.04.001 · Cited by 27

Biochemical perspectives on targeting KMT2 methyltransferases in cancer

Zhai, X., & Brownell, J. E. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.002 · Cited by 24

Structure-based design of ester compounds to inhibit MLL complex catalytic activity by targeting mixed lineage leukemia 1 (MLL1)–WDR5 interaction

Li, D., Wang, Z., Chen, W., Xie, Y.-Y., You, Q., & Guo, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.09.073 · Cited by 24

Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer

Yuan, Y., Qi, G., Shen, H., Guo, A., Cao, F., Zhu, Y., Xiao, C., Chang, W., & Zheng, S. (2018) · International Journal of Cancer · doi:10.1002/ijc.31736 · Cited by 24

Elevated H3K4me3 Through MLL2-WDR82 upon Hyperglycemia Causes Jagged Ligand Dependent Notch Activation to Interplay with Differentiation State of Endothelial Cells

Thakkar, N. P., Pereira, B. M. V., Katakia, Y. T., Ramakrishnan, S. K., Thakar, S., Sakhuja, A., Rajeev, G., Soorya, S., Thieme, K., & Majumder, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.839109 · Cited by 21

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα

Ramberger, E., Sapozhnikova, V., Kowenz‐Leutz, E., Zimmermann, K., Nicot, N., Nazarov, P. V., Pérez-Hernández, D., Reimer, U., Mertins, P., Dittmar, G., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102686 · Cited by 24

Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma

Wu, Y., Diao, P., Li, Z., Zhang, W., Wang, D., Wang, Y., & Cheng, J. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12708 · Cited by 22

Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML

Heyes, E. C., Schmidt, L., Manhart, G., Eder, T., Proietti, L., & Grebien, F. (2021) · Leukemia · doi:10.1038/s41375-021-01169-6 · Cited by 23

Discovery of Potent Small-Molecule Inhibitors of MLL Methyltransferase

Chern, T., Liu, L., Petrunak, E. M., Stuckey, J. A., Wang, M., Bernard, D., Zhou, H., Lee, S. H. F., Dou, Y., & Wang, S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00229 · Cited by 21

Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis

Cirilli, M., Bereshchenko, O., Ermakova, O. V., & Nerlov, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.10.002 · Cited by 22

WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think

Weissmiller, A. M., Fesik, S. W., & Tansey, W. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13010274 · Cited by 17

Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing

Valcárcel, G., López-Rubio, A. V., Lazarenkov, A., Berenguer, C., Calafell-Segura, J., Rodríguez‐Ubreva, J., Ballestar, E., & Sardina, J. L. (2025) · Science Advances · doi:10.1126/sciadv.adt1644 · Cited by 23

CEBPA mutants down-regulate AML cell susceptibility to NK-mediated lysis by disruption of the expression of NKG2D ligands, which can be restored by LSD1 inhibition

Liu, M., Du, M., Yu, J., Qian, Z., Gao, Y., Pan, W., Zhao, X., Wang, M., Li, H., Zheng, J., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2016158 · Cited by 20

WD40 repeat 43 mediates cell survival, proliferation, migration and invasion via vimentin in colorectal cancer

Li, Z., Feng, M., Zhang, J., Wang, X., Xu, E., Wang, C., Lin, F., Yang, Z., Yu, H., Guan, W., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02109-1 · Cited by 19

Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells

Florian, A. C., Woodley, C. M., Wang, J., Grieb, B. C., Slota, M. J., Guerrazzi, K., Hsu, C., Matlock, B. K., Flaherty, D. K., Lorey, S. L., et al. (2022) · NAR Cancer · doi:10.1093/narcan/zcac007 · Cited by 16

Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders

Gurung, R., Darlami, O., Pun, R. Y. K., Hyun, S., & Shin, D. (2023) · Cancers · doi:10.3390/cancers15153910 · Cited by 19

MLL1 regulates cytokine-driven cell migration and metastasis

Nair, P. R., Danilova, L., Gómez‐de‐Mariscal, E., Kim, D., Fan, R., Muñoz‐Barrutia, A., Fertig, E. J., & Wirtz, D. (2024) · Science Advances · doi:10.1126/sciadv.adk0785 · Cited by 19

An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer

Sun, G., Wang, C., Wang, S., Sun, H., Zeng, K., Zou, R., Lin, L., Liu, W., Sun, N., Song, H., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa787 · Cited by 19

Adenine DNA methylation associated with transcriptionally permissive chromatin is widespread across eukaryotes

Charria, P. R., Navarrete, C., Ovchinnikov, V. Y., Xu, L., Sarre, L. A., Shabardina, V., Księżopolska, E., Casacuberta, E., Lara‐Astiaso, D., Sebé-Pedrós, A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02409-6 · Cited by 19

Pseudogene ACTBP2 increases blood–brain barrier permeability by promoting KHDRBS2 transcription through recruitment of KMT2D/WDR5 in Aβ1–42 microenvironment

Liu, Q., Liu, X., Zhao, D., Ruan, X., Su, R. J., Shang, X., Wang, D., Yang, C., & Xue, Y. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00531-y · Cited by 19

Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction

Jaffry, U., & Wells, G. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220352 · Cited by 18

Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

Howard, G. C., Wang, J., Rose, K. L., Jones, C., Patel, P. R., Tsui, T., Florian, A. C., Vlach, L. M., Lorey, S. L., Grieb, B. C., et al. (2023) · eLife · doi:10.7554/elife.90683 · Cited by 22

Inhibitors of Protein Methyltransferases as Chemical Tools

Luo, M. (2015) · Epigenomics · doi:10.2217/epi.15.87 · Cited by 18

Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia

Wingelhofer, B., & Somervaille, T. C. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00850 · Cited by 18

Design of a fluorescent ligand targeting the S-adenosylmethionine binding site of the histone methyltransferase MLL1

Luan, Y., Blazer, L. L., Hu, H., Hajian, T., Zhang, J., Wu, H. Y., Houliston, S., Arrowsmith, C. H., Vedadi, M., & Zheng, Y. G. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01794g · Cited by 17

Targeting protein-protein interaction between MLL1 and reciprocal proteins for leukemia therapy

Wang, Z.-H., Li, D.-D., Chen, W.-L., You, Q.-D., & Guo, X.-K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.045 · Cited by 16

The Intersection of Structural and Chemical Biology - An Essential Synergy

Zuercher, W. J., Elkins, J. M., & Knapp, S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.12.005 · Cited by 16

TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells

Hernández-Quiles, M., Baak, R., Orea‐Soufi, A., Borgman, A., den Haan, S., Alcaraz, P. S., Jongejan, A., van Es, R. M., Velasco, G., Vos, H. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810535 · Cited by 16

Approaching the catalytic mechanism of protein lysine methyltransferases by biochemical and simulation techniques

Schnee, P., Pleiss, J., & Jeltsch, A. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2318547 · Cited by 18

The SCF–FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage

Hänle-Kreidler, S., Richter, K. T., & Hoffmann, I. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102703 · Cited by 14

Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma

Wu, J., Tan, X., Lin, J., Yuan, L., Chen, J., Qiu, L., & Huang, W. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.136 · Cited by 15

The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening

Ye, X., Zhang, R., Lian, F., Zhang, W., Lu, W., Han, J., Zhang, N., Jin, J., Luo, C., Chen, K., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.12.035 · Cited by 15

Therapeutic Vulnerabilities of Transcription Factors in AML

Khan, I., Eklund, E. A., & Gartel, A. L. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0115 · Cited by 15

WDR5 positively regulates p53 stability by inhibiting p53 ubiquitination

Xie, Q., Li, Z., & Chen, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.060 · Cited by 14

Transcriptome-Wide Identification of Coding and Noncoding RNA-Binding Proteins Defines the Comprehensive RNA Interactome of Leishmania mexicana

Kalesh, K., Wei, W., Mantilla, B. S., Roumeliotis, T. I., Choudhary, J. S., & Denny, P. W. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02422-21 · Cited by 14

Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation

Nguyen, N., Gudmundsson, K. O., Soltis, A. R., Oakley, K., Roy, K. R., Han, Y., Gurnari, C., Maciejewski, J. P., Crouch, G. D., Ernst, P., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103679 · Cited by 12

MLL regulates the actin cytoskeleton and cell migration by stabilising Rho GTPases via the expression of RhoGDI1

Chinchole, A., Lone, K. A., & Tyagi, S. (2022) · Journal of Cell Science · doi:10.1242/jcs.260042 · Cited by 13

Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery

Chan, A., Han, L., Delaney, C. D., Wang, X., Mukhaleva, E., Li, M., Yang, L., Pokharel, S. P., Mattson, N. M., Garcia, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk3127 · Cited by 14

Functional and Structural Characterization of Bub3·BubR1 Interactions Required for Spindle Assembly Checkpoint Signaling in Human Cells

Prinz, F., Puetter, V., Holton, S. J., Andres, D., Stegmann, C. M., Kwiatkowski, D., Prechtl, S., Petersen, K., Beckmann, G., Kreft, B., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702142 · Cited by 13

Epigenetic priming of mammalian embryonic enhancer elements coordinates developmental gene networks

Todd, C. D., Ijaz, J., Torabi, F., Dovgusha, O., Bevan, S., Cracknell, O., Lohoff, T., Clark, S. J., Argelaguet, R., Pearce, J., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03658-8 · Cited by 12

Quantitative Hydrogen–Deuterium Exchange Mass Spectrometry for Simultaneous Structural Characterization and Affinity Indexing of Single Target Drug Candidate Libraries

Wolf, E., Herasymenko, O., Kutera, M., Lento, C., Arrowsmith, C. H., Ackloo, S. Z., & Wilson, D. J. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01001 · Cited by 11

Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes

Barghout, S. H., Mann, M. K., Aman, A. M., Yu, Y., Alteen, M. G., Schimmer, A. D., Schapira, M., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00451 · Cited by 12

Comprehensive omics studies of p53 mutants in human cancer

Malhotra, L., Singh, A., Kaur, P., & Ethayathulla, A. S. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac015 · Cited by 12

Enzymatic nucleosome acetylation selectively affects activity of histone methyltransferases in vitro

Trush, V. V., Feller, C., Li, A. S. M., Allali‐Hassani, A., Szewczyk, M. M., Chau, I., Eram, M. S., Jiang, B., Luu, R., Zhang, F., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194845 · Cited by 11

Recent advances in developing degraders & inhibitors of lysine methyltransferases

Velez, J., Kanıskan, H. Ü., & Jin, J. J. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102356 · Cited by 11

Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors

Teuscher, K. B., Mills, J. J., Tian, J., Han, C., Meyers, K. M., Sai, J., South, T. M., Crow, M. M., Meveren, M. V., Sensintaffar, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01529 · Cited by 11

The MLL1 trimeric catalytic complex is a dynamic conformational ensemble stabilized by multiple weak interactions

Kaustov, L., Lemak, A. S., Wu, H., Faini, M., Fan, L., Fang, X., Zeng, H., Duan, S., Allali‐Hassani, A., Li, F., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz697 · Cited by 10

Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells

Saraon, P., Snider, J. D., Schormann, W., Rai, A., Radulovich, N., Sánchez‐Osuna, M., Coulombe‐Huntington, J., Huard, C., Mohammed, M., Lima‐Fernandes, E., et al. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167294 · Cited by 10

Hierarchical assembly of the MLL1 core complex regulates H3K4 methylation and is dependent on temperature and component concentration

Namitz, K. E. W., Tan, S., & Cosgrove, M. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102874 · Cited by 15

The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein- Protein Interaction

Ye, X., Chen, G., Jin, J., Zhang, B., Wang, Y., Cai, Z., & Ye, F. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190528080514 · Cited by 10

Exploitation of Proximity-Mediated Effects in Drug Discovery: An Update of Recent Research Highlights in Perturbing Pathogenic Proteins and Correlated Issues

Zhao, C., Wang, H., Zhan, W., Lv, X., & Ma, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00079 · Cited by 9

H3K4me3‐Mediated FOXJ2/SLAMF8 Axis Aggravates Thrombosis and Inflammation in β2GPI/Anti‐β2GPI‐Treated Monocytes

Tan, Y., Qiao, J., Yang, S., Liu, H., Wang, Q., Liu, Q., Feng, W., & Cui, L. (2024) · Advanced Science · doi:10.1002/advs.202309140 · Cited by 9

Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations

Volpe, G., Cauchy, P., Walton, D. S., Ward, C., Blakemore, D., Bayley, R., Clarke, M. L., Schmidt, L., Nerlov, C., García, P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800207 · Cited by 10

Mutant CEBPA promotes tolerance to inflammatory stress through deficient AP-1 activation

Cadefau-Fabregat, M., Martínez-Cebrián, G., Lorenzi, L., Weiss, F. D., Frank, A.-K., Castelló-García, J. M., Julià-Vilella, E., Gámez-García, A., Yera, L., de Castro, C. P. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58712-7 · Cited by 8

MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages

Du, Z., Wan, P., Du, M., Li, S., Yan, Q., Sun, S., Tang, C., Jiang, Z., Li, S., Shi, G., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66121-z · Cited by 8

ARID5B‐mediated LINC01128 epigenetically activated pyroptosis and apoptosis by promoting the formation of the BTF3/STAT3 complex in β2GPI/anti‐β2GPI‐treated monocytes

Tan, Y., Qiao, J., Yang, S., Wang, Q., Liu, H., Liu, Q., Feng, W., Yang, B., Li, Z., & Cui, L. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1539 · Cited by 8

p53 inactivation unmasks histone methylation-independent WDR5 functions that drive self-renewal and differentiation of pluripotent stem cells

Li, Q., Huang, Y., Xu, J., Mao, F., Zhou, B. O., Sun, L., Basinski, B. W., Aksu, M., Liu, J., Dou, Y., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.10.002 · Cited by 8

Design, synthesis, and initial evaluation of affinity-based small molecular probe for detection of WDR5

Chen, W., Li, D., Wang, Z., Xu, X., Zhang, X., Jiang, Z., Guo, X., & You, Q. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.11.018 · Cited by 8

Novel insights of acute myeloid leukemia with CEBPA deregulation: Heterogeneity dissection and re-stratification

Nie, Y., Su, L., Li, W., & Gao, S. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103379 · Cited by 8

Small molecule WDR5 inhibitors down-regulate lncRNA expression

Chang, J., Neugebauer, C., Koers, A. M. G., & Hart, P. ‘. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00605k · Cited by 6

DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets

Hu, Q., Cao, Y., Ren, P., Zhang, X., Li, F., Zhang, X., Cai, F., Zhang, R., Zhou, Y., Mei, L., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2518248123 · Cited by 7

Overlapping characteristics of weak interactions of two transcriptional regulators with WDR5

Ahmad, M., Imran, A., & Movileanu, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128969 · Cited by 7

PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis

Qin, Y., Dong, X., Lu, M., Jing, L., Chen, Q., Guan, F., Xiang, Z., Huang, J., Yang, C., He, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216952 · Cited by 7

Phage-Display Based Discovery and Characterization of Peptide Ligands against WDR5

Cao, J., Fan, T., Li, Y., Du, Z., Chen, L., Wang, Y., Wang, X., Shen, J., Huang, X., Xiong, B., et al. (2021) · Molecules · doi:10.3390/molecules26051225 · Cited by 7

The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2

Wu, C., Hsieh, Y., Tseng, H.-Y., Huang, Y.-H., Li, Y., Hung, T., Wang, S.-P., & Wu, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113663 · Cited by 8

Mechanism of Resistance to the WDR5 Inhibitor in MLL-Rearranged Leukemia

Liu, L., Shen, L., Ding, Z., He, M., Li, E., Tallarico, J. A., Jain, R. K., & Wang, H. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00108 · Cited by 7

Fragment screening for a protein-protein interaction inhibitor to WDR5

Dennis, M. L., Morrow, B. J., Dolezal, O., Cuzzupe, A. N., Stupple, A. E., Newman, J. M., Bentley, J. D., Hattarki, M. K., Nuttall, S. D., Foitzik, R. C., et al. (2019) · Structural Dynamics · doi:10.1063/1.5122849 · Cited by 7

Hierarchical assembly of the MLL1 core complex within a biomolecular condensate regulates H3K4 methylationPreprint

Namitz, K. E. W., Tan, S., & Cosgrove, M. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/870667 · Cited by 7

Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?

Owens, D. D. G., Maitland, M. E. R., Arrowsmith, C. H., & Baršytė-Lovejoy, D. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-110356 · Cited by 7

Recruitment of the MLL complex via specific interaction of the p30 variant of C/EBPα with Wdr5 is essential for development of acute myeloid leukemia

Grebien, F., Giambruno, R., Grover, A., Vittori, S., Schönegger, A., Bilban, M., Bock, C., Zuber, J. A., Bennett, K. L., Nerlov, C., et al. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.05.075

CEBPA-Mutant Acute Myeloid Leukemia is Sensitive to Small-Molecule-Mediated Inhibition of the Menin-MLL Interaction

Schmidt, L., Heyes, E. C., Scheiblecker, L., Eder, T., Volpe, G., Frampton, J., Nerlov, C., Valent, P., Grembecka, J. E., & Grebien, F. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.06.142

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex

Schmidt, L., Heyes, E. C., Scheiblecker, L., Eder, T., Volpe, G., Frampton, J., Nerlov, C., Valent, P., Grembecka, J. E., & Grebien, F. (2019) · Leukemia · doi:10.1038/s41375-019-0382-3 · Cited by 35

Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML

Heyes, E. C., Schmidt, L., Manhart, G., Eder, T., Proietti, L., & Grebien, F. (2021) · Leukemia · doi:10.1038/s41375-021-01169-6 · Cited by 23

Dissecting the Molecular Mechanisms of Mutant C/EBPalpha (p30) in Normal and Malignant Human Hematopoiesis.

Cammenga, J., Niebuhr, B., Horn, S., Delwel, R., & Stocking, C. (2005) · Blood · doi:10.1182/blood.v106.11.2995.2995